FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Lister

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Chromosomes, Human, Pair 14

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Paul Greaves; Maria Calaminici; Andrew Clear; Rita Coutinho; T Andrew Lister; Janet Matthews; Andrew Owen; Milensu Shanyinde; Andrew Wilson; John G Gribben
Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.
O Quintana-Bustamante; Y Reyal; J Vargaftig; S Lan-Lan Smith; Jude Fitzgibbon; E Griessinger; T Andrew Lister; Dominique Bonnet
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.
Rebecca L Auer; Jamie Cavenagh; Jeff K Davies; T Andrew Lister; Finlay MacDougall; Heather Oakervee; Denise Syndercombe-Court; David C Taussig; Samir Agrawal; John G Gribben
T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Lister (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Paul Greaves; Maria Calaminici; Andrew Clear; Rita Coutinho; T Andrew Lister; Janet Matthews; Andrew Owen; Milensu Shanyinde; Andrew Wilson; John G Gribben
Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):256-62.
2012: O Quintana-Bustamante; Y Reyal; J Vargaftig; S Lan-Lan Smith; Jude Fitzgibbon; E Griessinger; T Andrew Lister; Dominique Bonnet
Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.
Leukemia 2012;26(7):1537-46.
2012: Rebecca L Auer; Jamie Cavenagh; Jeff K Davies; T Andrew Lister; Finlay MacDougall; Heather Oakervee; Denise Syndercombe-Court; David C Taussig; Samir Agrawal; John G Gribben
T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies.
British journal of haematology 2012;157(5):580-5.
2012: Paul Greaves; Rebecca Auer; Daniel L P Brown; T Andrew Lister; Janet Matthews; Silvia Montoto; Andrew Wilson; John G Gribben
Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis.
British journal of haematology 2012;157(2):201-4.
2012: J Vargaftig; Fernando Anjos-Afonso; Jamie Cavenagh; John G Gribben; E Griessinger; T Andrew Lister; Heather Oakervee; David C Taussig; Dominique Bonnet
Frequency of leukemic initiating cells does not depend on the xenotransplantation model used.
Leukemia 2012;26(4):858-60.
2011: Arnaud Gandillet; S Park; Francois Lassailly; E Griessinger; J Vargaftig; A Filby; T Andrew Lister; D Bonnet
Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.
Leukemia 2011;25(5):770-80.
2011: David Wrench; Pamela Leighton; Christine F Skibola; Lucia Conde; Jean-Baptiste Cazier; Janet Matthews; Sameena Iqbal; Emanuela Carlotti; Csaba Bödör; Silvia Montoto; Maria Calaminici; John G Gribben; T Andrew Lister; Jude Fitzgibbon
SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.
Blood 2011;117(11):3147-50.
2010: Andrew J Clear; Abigail M Lee; Maria Calaminici; Alan G Ramsay; Kelly J Morris; Simon Hallam; Gavin Kelly; Finlay Macdougall; T Andrew Lister; John G Gribben
Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.
Blood 2010;115(24):5053-6.
2010: Jenny Dunne; Duncan M Gascoyne; T Andrew Lister; Hugh J M Brady; Olaf Heidenreich; Bryan D Young
AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
Cancer research 2010;70(10):3985-95.
2010: David C Taussig; Jacques Vargaftig; Farideh Miraki-Moud; Emmanuel Griessinger; Kirsty Sharrock; Tina Luke; Debra M Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.
Blood 2010;115(10):1976-84.
2009: Alan G Ramsay; Andrew J Clear; Gavin Kelly; Rewas Fatah; Janet Matthews; Finlay Macdougall; T Andrew Lister; Abigail M Lee; Maria Calaminici; John G Gribben
Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.
Blood 2009;114(21):4713-20.
2009: Rifca Le Dieu; David C Taussig; Alan G Ramsay; Richard Mitter; Farideh Miraki-Moud; Rewas Fatah; Abigail M Lee; T Andrew Lister; John G Gribben
Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts.
Blood 2009;114(18):3909-16.
2009: C O'Riain; D M O'Shea; Y Yang; R Le Dieu; John G Gribben; K Summers; J Yeboah-Afari; L Bhaw-Rosun; C Fleischmann; Charles A Mein; T Crook; P Smith; G Kelly; A Rosenwald; G Ott; E Campo; Lisa M Rimsza; Erlend Smeland; Wing C Chan; N Johnson; Randy D Gascoyne; S Reimer; Rita M Braziel; G W Wright; L M Staudt; T Andrew Lister; Jude Fitzgibbon
Array-based DNA methylation profiling in follicular lymphoma.
Leukemia 2009;23(10):1858-66.
2009: Rifca Le Dieu; David Taussig; T Andrew Lister; John G Gribben
Negative immunomagnetic selection of T cells from peripheral blood of presentation AML specimens.
Journal of immunological methods 2009;348(1-2):95-100.
2009: Derville O'Shea; Ciarán O'Riain; Manu Gupta; Rachel Waters; Youwen Yang; David Wrench; John G Gribben; Andreas Rosenwald; German Ott; Lisa M Rimsza; Harald Holte; Jean-Baptiste Cazier; Nathalie A Johnson; Elias Campo; Wing C Chan; Randy D Gascoyne; Bryan D Young; Louis M Staudt; T Andrew Lister; Jude Fitzgibbon
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.
Blood 2009;113(10):2298-301.
2008: Carolyn J Owen; Cynthia L Toze; Anna Koochin; Donna L Forrest; Clayton A Smith; Jane M Stevens; Shannon C Jackson; Man-Chiu Poon; Gary D Sinclair; Brian Leber; Peter R E Johnson; Anthony Macheta; John A L Yin; Michael J Barnett; T Andrew Lister; Jude Fitzgibbon
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.
Blood 2008;112(12):4639-45.
2008: Priya Virappane; Rosemary Gale; Robert Hills; Ioannis Kakkas; Karin Summers; Jane Stevens; Christopher Allen; Claire Green; Hilmar Quentmeier; Hans Drexler; Alan Burnett; David Linch; Dominique Bonnet; T Andrew Lister; Jude Fitzgibbon
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(33):5429-35.
2008: T Andrew Lister
Treatment of Stage IIIa Hodgkin's disease: long follow-up perspective.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5144-6.
2008: David C Taussig; Farideh Miraki-Moud; Fernando Anjos-Afonso; Daniel J Pearce; Kirsty Allen; Christopher Ridler; Debra M Lillington; Heather Oakervee; Jamie Cavenagh; Samir G Agrawal; T Andrew Lister; John G Gribben; Dominique Bonnet
Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells.
Blood 2008;112(3):568-75.
2008: Carolyn Owen; Priya Virappane; Mary Alikian; Irina Stasevich; Karin Summers; Debbie Lillington; Dominique Bonnet; Alan Burnett; Ken Mills; T Andrew Lister; Jude Fitzgibbon
WTX is rarely mutated in acute myeloid leukemia.
Haematologica 2008;93(6):947-8.
2008: Kajsa Paulsson; Jean-Baptiste Cazier; Finlay Macdougall; Jane Stevens; Irina Stasevich; Nikoletta Vrcelj; Tracy Chaplin; Debra M Lillington; T Andrew Lister; Bryan D Young
Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(18):6708-13.
2007: Simone Jüliger; Heidi Goenaga Infante; T Andrew Lister; Jude Fitzgibbon; Simon P Joel
Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species.
Cancer research 2007;67(22):10984-92.
2007: J Fitzgibbon; S Iqbal; A Davies; Derville O'Shea; Emanuela Carlotti; Tracy Chaplin; Janet Matthews; Manoj Raghavan; Andrew Norton; T Andrew Lister; Bryan D Young
Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma.
Leukemia 2007;21(7):1514-20.
2007: Ama Z S Rohatiner; Lee M Nadler; Andrew J Davies; John Apostolidis; Donna Neuberg; Janet Matthews; John G Gribben; Peter M Mauch; T Andrew Lister; Arnold S Freedman
Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(18):2554-9.
2007: Silvia Montoto; Andrew J Davies; Janet Matthews; Maria Calaminici; Andrew J Norton; John A Amess; Sarah Vinnicombe; Rachel Waters; Ama Z S Rohatiner; T Andrew Lister
Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2426-33.
2007: Sandra J Strauss; Karen Higginbottom; Simone Jüliger; Lenushka Maharaj; Paul Allen; David P Schenkein; T Andrew Lister; Simon P Joel
The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines.
Cancer research 2007;67(6):2783-90.
2006: Abigail M Lee; Andrew J Clear; Maria Calaminici; Andrew J Davies; Suzanne Jordan; Finlay MacDougall; Janet Matthews; Andrew J Norton; John G Gribben; T Andrew Lister; Lindsey K Goff
Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):5052-9.
2006: Sandra J Strauss; Franck Morschhauser; Juergen Rech; Roland Repp; Philippe Solal-Celigny; Pier Luigi Zinzani; Andreas Engert; Bertrand Coiffier; Dieter F Hoelzer; William A Wegener; Nick K W Teoh; David M Goldenberg; T Andrew Lister
Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3880-6.
2006: jeff davies; David C Taussig; Heather Oakervee; Andrew J Davies; Samir G Agrawal; John G Gribben; T Andrew Lister; Jamie Cavenagh
Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(14):e23-5.
2006: Sandra J Strauss; Lenushka Maharaj; Susan Hoare; Peter W Johnson; John A Radford; Sarah Vinnecombe; Lynda Millard; Ama Z S Rohatiner; Anthony Boral; Elizabeth Trehu; David P Schenkein; Frances R Balkwill; Simon P Joel; T Andrew Lister
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(13):2105-12.
2006: Kim W Last; Lenushka Maharaj; J Perry; S Strauss; Jude Fitzgibbon; T Andrew Lister; Simon P Joel
The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(5):773-9.
2006: Lan-Lan Smith; Daniel Pearce; Matthew L Smith; Michael J Jenner; T Andrew Lister; Dominique Bonnet; Lindsey K Goff; Jude Fitzgibbon
Development of a quantitative real-time polymerase chain reaction method for monitoring CEBPA mutations in normal karyotype acute myeloid leukaemia.
British journal of haematology 2006;133(1):103-5.
2006: Ling Yan Zhang; Matthew L Smith; Beate Schultheis; Jude Fitzgibbon; T Andrew Lister; Junia V Melo; Nicholas C P Cross; Jamie Cavenagh
A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy.
Leukemia research 2006;30(4):373-8.
2006: Daniel J Pearce; David C Taussig; Kazem Zibara; Lan-Lan Smith; Christopher M Ridler; Claude Preudhomme; Bryan D Young; Ama Z S Rohatiner; T Andrew Lister; Dominique Bonnet
AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.
Blood 2006;107(3):1166-73.
2005: David C Taussig; Daniel J Pearce; Catherine Simpson; Ama Z S Rohatiner; T Andrew Lister; Gavin Kelly; Jennifer L Luongo; Gwenn-Aël H Danet-Desnoyers; Dominique Bonnet
Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia.
Blood 2005;106(13):4086-92.
2005: Jude Fitzgibbon; Lan-Lan Smith; Manoj Raghavan; Matthew L Smith; Silvana Debernardi; Spyros Skoulakis; Debra M Lillington; T Andrew Lister; Bryan D Young
Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias.
Cancer research 2005;65(20):9152-4.
2005: Andrew J Davies; Abigail M Lee; C Taylor; A J Clear; Lindsey K Goff; S Iqbal; D Cuthbert-Heavens; Maria Calaminici; Andrew J Norton; T Andrew Lister; Jude Fitzgibbon
A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Leukemia 2005;19(8):1459-65.
2005: Daniel J Pearce; David C Taussig; Catherine Simpson; Kirsty Allen; Ama Z S Rohatiner; T Andrew Lister; Dominique Bonnet
Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.
Stem cells (Dayton, Ohio) 2005;23(6):752-60.
2005: Anthony Gordon; Heather Oakervee; B Kaya; J M Thomas; M J Barnett; Ama Z S Rohatiner; T Andrew Lister; Jamie Cavenagh; Charles J Hinds
Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care.
Anaesthesia 2005;60(4):340-7.
2005: Ama Z S Rohatiner; Walter Gregory; B Peterson; Ernest C Borden; Philippe Solal-Celigny; Anton Hagenbeek; Richard I Fisher; Michael Unterhalt; R Arranz; T Chisesi; A Aviles; T Andrew Lister
Meta-analysis to evaluate the role of interferon in follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2215-23.
2005: Ama Z S Rohatiner; T Andrew Lister
The clinical course of follicular lymphoma.
Best practice & research. Clinical haematology 2005;18(1):1-10.
2005: Manoj Raghavan; Debra M Lillington; Spyros Skoulakis; Silvana Debernardi; Tracy Chaplin; Nicola J Foot; T Andrew Lister; Bryan D Young
Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias.
Cancer research 2005;65(2):375-8.
2004: Matthew L Smith; Jamie Cavenagh; T Andrew Lister; Jude Fitzgibbon
Mutation of CEBPA in familial acute myeloid leukemia.
The New England journal of medicine 2004;351(23):2403-7.
2004: Andrew J Davies; Ama Z S Rohatiner; S Howell; Keith E Britton; S E Owens; Ivana N M Micallef; David P Deakin; Bernadette M Carrington; J A L Lawrance; Sarah Vinnicombe; S J Mather; J Clayton; R Foley; HA Jan; Stewart Kroll; M Harris; John A Amess; Andrew J Norton; T Andrew Lister; John A Radford
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1469-79.
2004: J-F Rossi; Achiel Van Hoof; K de Boeck; stephen johnson; Dominique Bron; Charles Foussard; T Andrew Lister; Christian Berthou; Mark H H Kramer; T J Littlewood; R E Marcus; Eric DECONINCK; M Montillo; O Guibon; SM Tollerfield
Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1260-7.
2004: T Andrew Lister
Who should receive myeloablative therapy for lymphoma?
The New England journal of medicine 2004;350(13):1277-8.
2004: Sameena Iqbal; Michael J Jenner; Karin E Summers; Andrew J Davies; Janet Matthews; Andrew J Norton; Maria Calaminici; Ama Z S Rohatiner; Jude Fitzgibbon; T Andrew Lister; Lindsey K Goff
Reliable detection of clonal IgH/Bcl2 MBR rearrangement in follicular lymphoma: methodology and clinical significance.
British journal of haematology 2004;124(3):325-8.
2003: David C Taussig; Andrew J Davies; Jamie Cavenagh; Heather Oakervee; Denise Syndercombe-Court; S Kelsey; John A Amess; Ama Z S Rohatiner; T Andrew Lister; M J Barnett
Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3060-5.
2003: Kim W Last; Victoria Cornelius; Trevor Delves; Christine Sieniawska; Jude Fitzgibbon; Andrew Norton; John A Amess; Andy Wilson; Ama Z S Rohatiner; T Andrew Lister
Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2335-41.
2003: Silvana Debernardi; Debra M Lillington; Tracy Chaplin; Simon Tomlinson; John A Amess; Ama Z S Rohatiner; T Andrew Lister; Bryan D Young
Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.
Genes, chromosomes & cancer 2003;37(2):149-58.
2003: Jennifer Snaddon; Matthew L Smith; Michael J Neat; Maxine Cambal-Parrales; Amanda Dixon-McIver; Rachael Arch; John A Amess; Ama Z S Rohatiner; T Andrew Lister; Jude Fitzgibbon
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.
Genes, chromosomes & cancer 2003;37(1):72-8.
2003: S Ngan; Ama Z S Rohatiner; Janet Matthews; A Williams; John A Amess; Andrew Norton; T Andrew Lister
Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001.
Seminars in oncology 2003;30(2):236-8.
2003: Magnus Björkholm; E Johansson; D Papamichael; Fredrik Celsing; Janet Matthews; T Andrew Lister; Ama Z S Rohatiner
Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
Seminars in oncology 2003;30(2):226-30.
2003: M L Smith; Jennifer Snaddon; Michael J Neat; M Cambal-Parrales; Rachael Arch; T Andrew Lister; Jude Fitzgibbon
Mutation of BRAF is uncommon in AML FAB type M1 and M2.
Leukemia 2003;17(1):274-5.
2002: Emanuela Carlotti; Francesca Pettenella; Ricardo Amaru; Sarah Slater; T Andrew Lister; Tiziano Barbui; Giuseppe Basso; Giovanni Cazzaniga; Alessandro Rambaldi; Andrea Biondi
Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
British journal of haematology 2002;118(4):1011-8.
2002: Karin E Summers; Andrew J Davies; Janet Matthews; Michael J Jenner; Victoria Cornelius; John A Amess; Andrew J Norton; Ama Z S Rohatiner; Jude Fitzgibbon; T Andrew Lister; Lindsey K Goff
The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction.
British journal of haematology 2002;118(2):563-6.
2002: Michael J Jenner; Karin E Summers; Andrew J Norton; John A Amess; Rachael Arch; Bryan D Young; T Andrew Lister; Jude Fitzgibbon; Lindsey K Goff
JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangements.
British journal of haematology 2002;118(2):550-8.
2002: Jennifer Snaddon; Michael J Neat; Jude Fitzgibbon; Matthew L Smith; Ama Z S Rohatiner; T Andrew Lister; John A Amess
Mutations in the runt homology domain of CBFalpha2 in myeloid malignancies with acquired trisomy 21.
Cancer genetics and cytogenetics 2002;136(2):151-2.
2002: John A Radford; Ama Z S Rohatiner; W D J Ryder; David P Deakin; T Barbui; N P Lucie; A Rossi; D J Dunlop; Richard A Cowan; Peter M Wilkinson; R K Gupta; RD James; J Shamash; James Chang; Derek Crowther; T Andrew Lister
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2988-94.
2002: Christopher D Dalley; Deborah L Lillington; Michael Bradburn; Maxine Carter; John A Amess; Ama Z S Rohatiner; T Andrew Lister
Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(5):237-43.
2002: Debra M Lillington; Ivana N M Micallef; E Carpenter; Michael J Neat; John A Amess; Janet Matthews; Nicola J Foot; T Andrew Lister; Bryan D Young; Ama Z S Rohatiner
Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 1():40-3.
2002: Margaret A Shipp; Kenneth N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill P Mesirov; Donna Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
Nature medicine 2002;8(1):68-74.
2001: Michael J Neat; Nicola J Foot; Michael J Jenner; Lindsey K Goff; K Ashcroft; D Burford; A Dunham; Andrew Norton; T Andrew Lister; Jude Fitzgibbon
Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 Mb region of 13q32-33.
Genes, chromosomes & cancer 2001;32(3):236-43.
2001: Mark S Kaminski; Andrew D Zelenetz; Oliver W Press; M Saleh; J Leonard; L Fehrenbacher; T Andrew Lister; RJ Stagg; George Tidmarsh; Stewart Kroll; Richard L Wahl; Susan J Knox; Julie M Vose
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3918-28.
2001: JM Foran; Andrew J Norton; Ivana N M Micallef; David C Taussig; John A Amess; Ama Z S Rohatiner; T Andrew Lister
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis.
British journal of haematology 2001;114(4):881-3.
2001: A Rohatiner; J Radford; D Deakin; Helena Earl; S B Love; O Price; A Wilson; T Andrew Lister
A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.
British journal of cancer 2001;85(1):29-35.
2001: Ivana N M Micallef; Ama Z S Rohatiner; M Carter; M Boyle; S Slater; John A Amess; T Andrew Lister
Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia.
British journal of haematology 2001;113(2):443-5.
2001: Debra M Lillington; Ivana N M Micallef; E Carpenter; Michael J Neat; John A Amess; Janet Matthews; Nicola J Foot; Bryan D Young; T Andrew Lister; Ama Z S Rohatiner
Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(9):2472-81.
2001: Karin E Summers; Lindsey K Goff; A G Wilson; RK Gupta; T Andrew Lister; Jude Fitzgibbon
Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):420-4.
2001: Christopher D Dalley; T Andrew Lister; J D Cavenagh; Ama Z S Rohatiner
Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia.
British journal of cancer 2001;84(1):147.
2000: Lindsey K Goff; Michael J Neat; CR Crawley; L Jones; E Jones; T Andrew Lister; RK Gupta
The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma.
British journal of haematology 2000;111(2):618-25.
2000: Kim W Last; Lindsey K Goff; Karin E Summers; Michael J Neat; Michael J Jenner; CR Crawley; Ama Z S Rohatiner; Jude Fitzgibbon; T Andrew Lister
Familial follicular lymphoma: a case report with molecular analysis.
British journal of haematology 2000;110(3):744-5.
2000: Ama Z S Rohatiner; Renato Bassan; Roberto Raimondi; John A Amess; S Arnott; A Personen; Francesco Rodeghiero; Tiziano Barbui; Michael Bradburn; M Carter; T Andrew Lister
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1007-15.
2000: CR Crawley; JM Foran; RK Gupta; Ama Z S Rohatiner; Karin E Summers; Janet Matthews; Ivana N M Micallef; John A Radford; stephen johnson; Peter WM Johnson; J W Sweetenham; T Andrew Lister
A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):861-5.
2000: J Shamash; J Walewski; John Apostolidis; A M Wilson; JM Foran; RK Gupta; Ama Z S Rohatiner; Stephen M Kelsey; T Andrew Lister
Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):857-60.
2000: J Shamash; S M Lee; John A Radford; Ama Z S Rohatiner; J Chang; Godfrey R Morgenstern; John Howard Scarffe; David P Deakin; T Andrew Lister
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: a two centre study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):715-9.
2000: JM Foran; RK Gupta; David Cunningham; R A Popescu; Anthony H Goldstone; J W Sweetenham; Ruth Pettengell; Peter WM Johnson; E Bessell; B Hancock; Karin E Summers; J Hughes; Ama Z S Rohatiner; T Andrew Lister
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response.
British journal of haematology 2000;109(1):81-8.
2000: Ivana N M Micallef; Debra M Lillington; John Apostolidis; John A Amess; Michael J Neat; Janet Matthews; T Clark; JM Foran; A Salam; T Andrew Lister; Ama Z S Rohatiner
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):947-55.
2000: John Apostolidis; RK Gupta; D Grenzelias; Peter WM Johnson; Vassiliki Pappa; Karin E Summers; A Salam; K Adams; Andrew J Norton; John A Amess; Janet Matthews; Michael Bradburn; T Andrew Lister; Ama Z S Rohatiner
High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):527-36.
2000: Ivana N M Micallef; John Apostolidis; Ama Z S Rohatiner; C Wiggins; CR Crawley; JM Foran; M Leonhardt; Michael Bradburn; E Okukenu; A Salam; Janet Matthews; Jamie Cavenagh; RK Gupta; T Andrew Lister
Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(6):367-73.
2000: Jude Fitzgibbon; Michael J Neat; L Jones; Nicola J Foot; T Andrew Lister; R K Gupta
Assignment of B-cell lymphoma 6, member B (zinc finger protein) gene (BCL6B) to human chromosome 17p13.1 by in situ hybridization.
Cytogenetics and cell genetics 2000;89(3-4):218-9.
2000: Jude Fitzgibbon; Michael J Neat; Nicola J Foot; Alexander S Hill; T Andrew Lister; R K Gupta
Assignment of brain acid-soluble protein 1 (BASP1) to human chromosome 5p15.1-->p14, differential expression in human cancer cell lines as a result of alterations in gene dosage.
Cytogenetics and cell genetics 2000;89(3-4):147-9.
2000: JM Foran; David Cunningham; Bertrand Coiffier; Philippe Solal-Celigny; Felix Reyes; M Ghielmini; Peter WM Johnson; Christian Gisselbrecht; Michael Bradburn; Janet Matthews; T Andrew Lister
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():117-21.
2000: JM Foran; Ama Z S Rohatiner; David Cunningham; R A Popescu; Philippe Solal-Celigny; M Ghielmini; Bertrand Coiffier; Peter WM Johnson; Christian Gisselbrecht; Felix Reyes; John A Radford; E M Bessell; B Souleau; A Benzohra; T Andrew Lister
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):317-24.
1999: John Apostolidis; Debra M Lillington; Lindsey K Goff; E L Jones; T Andrew Lister; R K Gupta
More about: B-cell non-Hodgkin's lymphoma: evidence for the t(14;18) translocation in all hematopoietic cell lineages.
Journal of the National Cancer Institute 1999;91(19):1687-8.
1999: D Papamichael; Andrew J Norton; JM Foran; CW Mulatero; J Mathews; John A Amess; Michael Bradburn; T Andrew Lister; Ama Z S Rohatiner
Immunocytoma: a retrospective analysis from St Bartholomew's Hospital-1972 to 1996.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2847-53.
1999: JM Foran; D Oscier; J Orchard; stephen johnson; M Tighe; M H Cullen; P G de Takats; C Kraus; M Klein; T Andrew Lister
Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1574-9.
1999: Ivana N M Micallef; A Kirk; Andrew Norton; JM Foran; Ama Z S Rohatiner; T Andrew Lister
Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma.
Blood 1999;93(7):2427-8.
1999: S Slater; M Carter; K Howe; John A Amess; Ama Z S Rohatiner; T Andrew Lister
Acute promyelocytic leukaemia: a retrospective analysis of patients treated at St. Bartholomew's Hospital 1969-1995.
Annals of hematology 1999;78(3):131-7.
1999: JM Foran; Ama Z S Rohatiner; Bertrand Coiffier; T Barbui; stephen johnson; W Hiddemann; John A Radford; Andrew J Norton; SM Tollerfield; M P Wilson; T Andrew Lister
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):546-53.
1999: John Apostolidis; JM Foran; Peter WM Johnson; Andrew Norton; John A Amess; Janet Matthews; Michael Bradburn; T Andrew Lister; Ama Z S Rohatiner
Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):216-21.
1999: P Kessar; Andrew Norton; A Z Rohatiner; T Andrew Lister; Rodney H Reznek
CT appearances of mucosa-associated lymphoid tissue (MALT) lymphoma.
European radiology 1999;9(4):693-6.
1998: Vassiliki Pappa; S Wilkes; A Salam; Bryan D Young; T Andrew Lister; Ama Z S Rohatiner
Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
Bone marrow transplantation 1998;22(6):553-8.
1998: JM Foran; John Apostolidis; D Papamichael; Andrew J Norton; Janet Matthews; John A Amess; T Andrew Lister; Ama Z S Rohatiner
High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(8):865-9.
1998: Jonathan Shamash; A H Salam; Derek Davies; A Williams; S Joel; T Andrew Lister
In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma.
British journal of cancer 1998;77(10):1598-603.
1997: T Andrew Lister
Follicular lymphoma: grounds for optimism.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():89-92.
1996: Dimitri Papamichael; T Andrews; D Owen; M Carter; John A Amess; T Andrew Lister; Ama Z S Rohatiner
Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony stimulating factor.
Annals of hematology 1996;73(6):259-63.
1996: Maurice L Slevin; S E Nichols; S M Downer; P Wilson; T Andrew Lister; S Arnott; J Maher; R L Souhami; J S Tobias; A H Goldstone; M Cody
Emotional support for cancer patients: what do patients really want?
British journal of cancer 1996;74(8):1275-9.
1996: V I Pappa; Hero Hussain; Rodney H Reznek; J Whelan; A J Norton; A M Wilson; S Love; T Andrew Lister; Ama Z S Rohatiner
Role of image-guided core-needle biopsy in the management of patients with lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2427-30.
1996: S Porter; Alexander Walker; T Andrew Lister; E J Watts; Debra M Lillington
Acute myelogenous leukemia with dup(1)(p22p36),dup(1)(p22p36): a novel case?
Cancer genetics and cytogenetics 1996;87(1):48-51.
1996: Joanne M A Meerabux; M L Yaspo; A J Roebroek; W J Van de Ven; T Andrew Lister; Bryan D Young
A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas.
Cancer research 1996;56(3):448-51.
1995: J Shamash; D C Davies; A Salam; Ama Z S Rohatiner; Bryan D Young; T Andrew Lister
Induction of CD80 expression in low-grade B cell lymphoma--a potential immunotherapeutic target.
Leukemia 1995;9(8):1349-52.
1995: V I Pappa; A J Norton; R K Gupta; A M Wilson; Ama Z S Rohatiner; T Andrew Lister
Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(6):559-65.
1995: A J Norton; J Matthews; V Pappa; J Shamash; S Love; Ama Z S Rohatiner; T Andrew Lister
Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(3):249-56.
1995: P W Johnson; Ama Z S Rohatiner; J S Whelan; C G Price; S Love; J Lim; J Matthews; A J Norton; John A Amess; T Andrew Lister
Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):140-7.
1995: P Banerjee; P K MacCallum; R W Walker; T Andrew Lister
Polyradiculopathy complicating acute lymphoblastic leukemia.
Hematological oncology 1995;13(1):45-7.
1994: mark bower; P Parry; M Carter; Debra M Lillington; John A Amess; T Andrew Lister; G Evans; Bryan D Young
Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5.
Blood 1994;84(11):3776-80.
1994: P W Johnson; J Fearnley; P Domizio; J Goldin; K Nagendran; J Gawler; Ama Z S Rohatiner; T Andrew Lister
Neurological illness following treatment with fludarabine.
British journal of cancer 1994;70(5):966-8.
1994: Amit Oza; S Tonks; J Lim; M A Fleetwood; T Andrew Lister; J G Bodmer
A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease.
Cancer research 1994;54(19):5101-5.
1994: Ama Z S Rohatiner; T Andrew Lister
Management of follicular lymphoma.
Current opinion in oncology 1994;6(5):473-9.
1994: R K Gupta; T Andrew Lister; J G Bodmer
The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease.
Leukemia 1994;8(8):1337-41.
1994: B Gibbons; Debra M Lillington; S Monard; Bryan D Young; K L Cheung; T Andrew Lister; L Kearney
Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders.
Genes, chromosomes & cancer 1994;10(4):244-9.
1994: Ama Z S Rohatiner; F d'Amore; Bertrand Coiffier; D Crowther; M Gospodarowicz; P Isaacson; T Andrew Lister; A Norton; P Salem; M Shipp
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):397-400.
1994: Debra M Lillington; S Monard; P W Johnson; M L Evans; L U Kearney; T Andrew Lister; Bryan D Young; B Gibbons
The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9).
Leukemia 1994;8(4):560-3.
1994: P W Johnson; C G Price; T Smith; F E Cotter; Joanne M A Meerabux; Ama Z S Rohatiner; Bryan D Young; T Andrew Lister
Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):798-805.
1994: Ama Z S Rohatiner; J S Whelan; R K Ganjoo; A J Norton; A Wilson; T Andrew Lister
Mediastinal large-cell lymphoma with sclerosis (MLCLS).
British journal of cancer 1994;69(3):601-4.
1994: Joanne M A Meerabux; F E Cotter; L Kearney; Dean Nizetic; S Dhut; B Gibbons; T Andrew Lister; Bryan D Young
Molecular cloning of a novel 11q23 breakpoint associated with non-Hodgkin's lymphoma.
Oncogene 1994;9(3):893-8.
1994: mark bower; P Parry; B Gibbons; John A Amess; T Andrew Lister; Bryan D Young; G A Evans
Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment.
Leukemia 1994;8(2):226-9.
1994: John A Radford; J S Whelan; Ama Z S Rohatiner; David P Deakin; M Harris; A G Stansfeld; Ric Swindell; Peter M Wilkinson; R D James; T Andrew Lister
Weekly VAPEC-B chemotherapy for high grade non-Hodgkin's lymphoma: results of treatment in 184 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(2):147-51.
1994: Ama Z S Rohatiner; Arnold S Freedman; Lee M Nadler; J Lim; T Andrew Lister
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():143-6.
1994: R K Gupta; T Andrew Lister; J G Bodmer
Proliferation of Reed-Sternberg cells and variants in Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 1():117-9.
1994: Ama Z S Rohatiner; T Andrew Lister
The management of follicular lymphoma.
Drugs 1994;47 Suppl 6():10-8.
1994: T Karmiris; Ama Z S Rohatiner; S Love; M Carter; R K Ganjoo; John A Amess; A J Norton; T Andrew Lister
The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.
Hematological oncology 1994;12(1):29-39.
1993: A Tuszynski; S Dhut; Bryan D Young; T Andrew Lister; Ama Z S Rohatiner; John A Amess; Tracy Chaplin; E Dorey; B Gibbons
Detection and significance of bcr-abl mRNA transcripts and fusion proteins in Philadelphia-positive adult acute lymphoblastic leukemia.
Leukemia 1993;7(10):1504-8.
1993: A Pigaditou; Ama Z S Rohatiner; J S Whelan; P W Johnson; R K Ganjoo; A Rossi; A J Norton; John A Amess; J Lim; T Andrew Lister
Fludarabine in low-grade lymphoma.
Seminars in oncology 1993;20(5 Suppl 7):24-7.
1993: P W Johnson; S M Watt; D R Betts; D Davies; S Jordan; A J Norton; T Andrew Lister
Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system.
Blood 1993;82(6):1848-57.
1993: mark bower; Tracy Chaplin; S Das; L Kearney; B Gibbons; J H Riley; T Andrew Lister; Bryan D Young
The isolation of a yeast artificial chromosome which spans the chromosome 11q23 region involved in a number of translocations in acute leukaemias.
Leukemia 1993;7 Suppl 2():S34-9.
1993: R K Gupta; A J Norton; T Andrew Lister; J G Bodmer
p53 protein expression in Reed-Sternberg cells of Hodgkin's disease.
Leukemia 1993;7 Suppl 2():S31-3.
1993: R K Ganjoo; P W Johnson; M L Evans; A Williams; Ama Z S Rohatiner; T Andrew Lister; J S Malpas
Recombinant interferon-alpha 2b and high dose methyl prednisolone in relapsed and resistant multiple myeloma.
Hematological oncology 1993;11(4):179-86.
1993: P W Johnson; J Whelan; S Longhurst; K Stepniewska; Janet Matthews; John A Amess; Andrew Norton; Ama Z S Rohatiner; T Andrew Lister
Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
British journal of cancer 1993;67(4):792-7.
1993: Debra M Lillington; P K MacCallum; T Andrew Lister; B Gibbons
Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature.
Leukemia 1993;7(4):527-31.
1993: C L Davis; Ama Z S Rohatiner; J Lim; J S Whelan; Amit Oza; John A Amess; S Love; E Stead; T Andrew Lister
The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen-year period.
British journal of haematology 1993;83(3):404-11.
1993: Ama Z S Rohatiner; P Johnson; A Norton; J Matthews; T Andrew Lister
The treatment of low grade non-Hodgkin's lymphoma in elderly people.
Hematological oncology 1993;11 Suppl 1():62-6.
1993: J S Whelan; R Ganjoo; P W Johnson; Ama Z S Rohatiner; T Andrew Lister
Treatment of low grade non-Hodgkin's lymphomas with fludarabine.
Leukemia & lymphoma 1993;10 Suppl():35-7.
1993: P W Johnson; T Andrew Lister
Can the polymerase chain reaction be used to direct therapy?
Leukemia & lymphoma 1993;10 Suppl():151-2.
1993: P W Johnson; J W Sweetenham; P McCallum; A J Norton; Ama Z S Rohatiner; T Andrew Lister
E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(1):63-7.
1992: D R Betts; Ama Z S Rohatiner; M L Evans; S M Rassam; T Andrew Lister; B Gibbons
Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature.
Leukemia 1992;6(12):1250-6.
1992: S Tonks; Amit Oza; T Andrew Lister; J G Bodmer
Association of HLA-DPB with Hodgkin's disease.
Lancet 1992;340(8825):968-9.
1992: R K Gupta; A J Norton; I W Thompson; T Andrew Lister; J G Bodmer
p53 expression in Reed-Sternberg cells of Hodgkin's disease.
British journal of cancer 1992;66(4):649-52.
1992: L Kearney; mark bower; B Gibbons; S Das; Tracy Chaplin; Elisabeth P Nacheva; Judith M Chessells; B Reeves; J H Riley; T Andrew Lister
Chromosome 11q23 translocations in both infant and adult acute leukemias are detected by in situ hybridization with a yeast artificial chromosome.
Blood 1992;80(7):1659-65.
1992: S E Slater; P K Maccallum; F Birjandi; B Gibbons; T Andrew Lister
Acute myelogenous leukemia (AML) and diabetes insipidus (DI): further association with monosomy 7.
Hematological oncology 1992;10(3-4):221-3.
1992: Trivadi Ganesan; Amit Oza; N Perry; J D'Ardenne; S Arnott; A G Stansfeld; W S Shand; P F Wrigley; T Andrew Lister
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(5):349-56.
1992: R K Gupta; J S Whelan; T Andrew Lister; Bryan D Young; J G Bodmer
Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease.
Blood 1992;79(8):2084-8.
1992: J S Whelan; C L Davis; Ama Z S Rohatiner; M Leahy; P K MacCallum; R K Gupta; J Matthews; A J Norton; John A Amess; T Andrew Lister
Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy.
Hematological oncology 1992;10(2):87-94.
1991: T D Karmiris; T Andrew Lister; Ama Z S Rohatiner
Chronic lymphocytic leukaemia.
British journal of hospital medicine 1991;46(6):379-81, 384-5.
1991: Amit Oza; M Leahy; E Dorey; C L Davis; John A Amess; M Horton; Ama Z S Rohatiner; P F Wrigley; T Andrew Lister
Recombinant human granulocyte macrophage colony stimulating factor following alternating non cross resistant chemotherapy in Hodgkin's disease.
Hematological oncology 1991;9(6):337-47.
1991: Ama Z S Rohatiner; T Andrew Lister
New approaches to the treatment of follicular lymphoma.
British journal of haematology 1991;79(3):349-54.
1991: Ama Z S Rohatiner; T Andrew Lister
Myeloablative therapy for follicular lymphoma.
Hematology/oncology clinics of North America 1991;5(5):1003-12.
1991: C G Price; Joanne M A Meerabux; S Murtagh; F E Cotter; Ama Z S Rohatiner; Bryan D Young; T Andrew Lister
The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1527-32.
1991: Amit Oza; M Leahy; J Lim; W Gregory; A G Stansfeld; P F Wrigley; T Andrew Lister
The treatment of stage IIIA Hodgkin's disease--total nodal irradiation versus combination chemotherapy: either or neither.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(8):1514-6.
1991: C G Price; A Tuszynski; Suzanne M Watt; S J Murdoch; T Andrew Lister; Bryan D Young
Detection of additional JH/BCL2 translocations in follicular lymphoma.
Leukemia 1991;5(7):548-54.
1991: J S Whelan; C L Davis; S Rule; M Ranson; O P Smith; A B Mehta; D Catovsky; Ama Z S Rohatiner; T Andrew Lister
Fludarabine phosphate for the treatment of low grade lymphoid malignancy.
British journal of cancer 1991;64(1):120-3.
1991: J S Whelan; Rodney H Reznek; S J Daniell; A J Norton; T Andrew Lister; Ama Z S Rohatiner
Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin's lymphoma.
British journal of cancer 1991;63(3):460-2.
1991: C G Price; Ama Z S Rohatiner; W Steward; David P Deakin; N Bailey; A Norton; G Blackledge; D Crowther; T Andrew Lister
Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():141-5.
1991: T Andrew Lister
The management of follicular lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():131-5.
1991: C G Price; Ama Z S Rohatiner; W Steward; David P Deakin; N Bailey; A Norton; G Blackledge; D Crowther; T Andrew Lister
Interferon alfa-2b in addition to chlorambucil in the treatment of follicular lymphoma: preliminary results of a randomized trial in progress.
European journal of cancer (Oxford, England : 1990) 1991;27 Suppl 4():S34-6.
1990: T Andrew Lister; D Crowther
Staging for Hodgkin's disease.
Seminars in oncology 1990;17(6):696-703.
1990: Trivadi Ganesan; P F Wrigley; P A Murray; A G Stansfeld; A J d'Ardenne; S Arnott; A Jones; W S Shand; J S Malpas; T Andrew Lister
Radiotherapy for stage I Hodgkin's disease: 20 years experience at St Bartholomew's Hospital.
British journal of cancer 1990;62(2):314-8.
1990: M A Richards; I Mootoosamy; Rodney H Reznek; J A Webb; T Andrew Lister
Renal involvement in patients with non-Hodgkin's lymphoma: clinical and pathological features in 23 cases.
Hematological oncology 1990;8(2):105-10.
1990: J Tucker; E Dorey; Walter Gregory; A P Simpson; John A Amess; T Andrew Lister; M A Horton
Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
Hematological oncology 1990;8(1):47-58.
1990: C L Davis; Ama Z S Rohatiner; John A Amess; J Lim; T Andrew Lister
Treatment of recurrent acute myelogenous leukaemia at a single centre over a 10-year period.
Haematology and blood transfusion 1990;33():339-41.
1990: F E Cotter; Chris Price; Bryan D Young; T Andrew Lister
Minimal residual disease in leukaemia and lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(3):167-70.
1990: J Tucker; A E Thomas; Walter Gregory; Trivadi Ganesan; S T Malik; John A Amess; J Lim; L Willis; Ama Z S Rohatiner; T Andrew Lister
Acute myeloid leukemia in elderly adults.
Hematological oncology 1990;8(1):13-21.
1989: T Andrew Lister; D Crowther; S B Sutcliffe; E Glatstein; George P Canellos; R C Young; STEVEN ROSENBERG; C A Coltman; M Tubiana
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1630-6.
1989: S T Malik; J Tucker; Ama Z S Rohatiner; W Brace; T Andrew Lister
Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia.
Hematological oncology 1989;7(6):423-7.
1989: S T Malik; John A Amess; A J D'Ardenne; T Andrew Lister
Hairy cell leukemia--mediastinal involvement. A report of two cases and review of the literature.
Hematological oncology 1989;7(4):303-6.
1989: J G Bodmer; S Tonks; Amit Oza; T Andrew Lister; W F Bodmer
HLA-DP based resistance to Hodgkin's disease.
Lancet 1989;1(8652):1455-6.
1989: C G Price; F E Cotter; O M Curling; A J D'Ardenne; Ama Z S Rohatiner; Bryan D Young; T Andrew Lister
Polymerase chain reaction to confirm extranodal progression of follicular lymphoma.
Lancet 1989;1(8647):1132.
1989: E L Dorey; S V Outram; A Holder; Ama Z S Rohatiner; F E Cotter; M Deane; A G Stansfeld; T Andrew Lister; M A Horton
Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).
British journal of cancer 1989;59(5):772-4.
1989: M A Richards; P A Hall; Walter Gregory; H S Dhaliwal; A G Stansfeld; John A Amess; T Andrew Lister
Lymphoplasmacytoid and small cell centrocytic non-Hodgkin's lymphoma--a retrospective analysis from St Bartholomew's Hospital 1972-1986.
Hematological oncology 1989;7(1):19-35.
1989: M A Richards; Walter Gregory; P A Hall; H S Dhaliwal; J Fernandez; A G Stansfeld; A E Jones; T Andrew Lister
Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985.
Hematological oncology 1989;7(1):1-18.
1989: F E Cotter; P A Hall; B D Young; T Andrew Lister
Simultaneous presentation of B- and T-cell malignant lymphoma.
Haematology and blood transfusion 1989;32():97-100.
1988: M A Richards; J A Webb; S Malik; S E Jewell; John A Amess; T Andrew Lister
Low field strength magnetic resonance imaging of bone marrow in acute leukaemia.
Hematological oncology 1988;6(4):285-90.
1988: M A Richards; J A Webb; S E Jewell; John A Amess; P F Wrigley; T Andrew Lister
Low field strength magnetic resonance imaging of bone marrow in patients with malignant lymphoma.
British journal of cancer 1988;57(4):412-5.
1988: M A Richards; J A Webb; S E Jewell; A G Stansfeld; T Andrew Lister; P F Wrigley
Low field strength magnetic resonance imaging of the spleen: results from volunteers and patients with lymphoma.
British journal of cancer 1988;57(4):408-11.
1987: L C Walker; Trivadi Ganesan; S Dhut; B Gibbons; T Andrew Lister; J Rothbard; Bryan D Young
Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia.
Nature 1987;329(6142):851-3.
1987: T Andrew Lister; Ama Z S Rohatiner; R Bassan; W Gregory; L Willis; M J Barnett; J Waxman; M A Richards; Trivadi Ganesan; J Tucker
Conventional dose cytosine arabinoside in combination chemotherapy for acute myelogenous leukemia.
Seminars in oncology 1987;14(2 Suppl 1):53-4.
1987: M J Barnett; A M Man; M A Richards; J H Waxman; P F Wrigley; T Andrew Lister
OPEC chemotherapy (vincristine, prednisolone, etoposide and chlorambucil) for refractory and recurrent Hodgkin's disease.
Hematological oncology 1987;5(2):79-82.
1987: Trivadi Ganesan; H S Dhaliwal; M S Dorreen; A G Stansfeld; J A Habeshaw; T Andrew Lister
Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study.
British journal of cancer 1987;55(4):437-42.
1987: M J Barnett; Ama Z S Rohatiner; J E Kingston; K E Adams; E L Batten; R Bassan; P E Thorpe; M A Horton; J S Malpas; T Andrew Lister
In vitro treatment of bone marrow from patients with T-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma using the immunotoxin WT1-ricin A.
Haematology and blood transfusion 1987;31():57-8.
1987: R Bassan; Ama Z S Rohatiner; W Gregory; John A Amess; R Biruls; M J Barnett; T Andrew Lister
The treatment of acute myelogenous leukemia.
Haematology and blood transfusion 1987;31():35-6.
1986: M J Barnett; M F Greaves; John A Amess; Walter Gregory; Ama Z S Rohatiner; H S Dhaliwal; M L Slevin; R Biruls; J S Malpas; T Andrew Lister
Treatment of acute lymphoblastic leukaemia in adults.
British journal of haematology 1986;64(3):455-68.
1986: M A Richards; J A Webb; R H Reznek; G Davies; S E Jewell; W S Shand; P F Wrigley; T Andrew Lister
Detection of spread of malignant lymphoma to the liver by low field strength magnetic resonance imaging.
British medical journal (Clinical research ed.) 1986;293(6555):1126-8.
1986: C J Gallagher; Walter Gregory; A E Jones; A G Stansfeld; M A Richards; H S Dhaliwal; J S Malpas; T Andrew Lister
Follicular lymphoma: prognostic factors for response and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(10):1470-80.
1986: M S Dorreen; Walter Gregory; P F Wrigley; A G Stansfeld; T Andrew Lister
Second primary malignant neoplasms in patients treated for Hodgkin's disease at St Bartholomew's Hospital.
Hematological oncology 1986;4(2):149-61.
1985: M A Richards; M J Barnett; J H Waxman; Ama Z S Rohatiner; H S Dhaliwal; C J Gallagher; T Andrew Lister
The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma.
Seminars in oncology 1985;12(2 Suppl 3):223-6.
1985: M J Barnett; M A Richards; Trivadi Ganesan; J H Waxman; B F Smith; M G Butler; Ama Z S Rohatiner; M L Slevin; T Andrew Lister
Central nervous system toxicity of high-dose cytosine arabinoside.
Seminars in oncology 1985;12(2 Suppl 3):227-32.
1985: M J Barnett; J H Waxman; M A Richards; Trivadi Ganesan; K S Bragman; Ama Z S Rohatiner; T Andrew Lister
High-dose cytosine arabinoside in the initial treatment of acute leukemia.
Seminars in oncology 1985;12(2 Suppl 3):133-8.
1985: M J Barnett; Trivadi Ganesan; J H Waxman; M A Richards; B F Smith; Ama Z S Rohatiner; H S Dhaliwal; M L Slevin; T Andrew Lister
Neurotoxicity of high-dose cytosine arabinoside.
Progress in experimental tumor research 1985;29():177-88.
1985: M J Barnett; Ama Z S Rohatiner; M A Richards; J H Waxman; Trivadi Ganesan; A Miller; R Biruls; T Andrew Lister
The feasibility of opal/high dose Ara-C treatment of adult acute lymphoblastic leukaemia.
Haematology and blood transfusion 1985;29():53-5.
1984: M S Dorreen; P F Wrigley; A E Jones; W S Shand; A G Stansfeld; T Andrew Lister
The management of localized, infradiaphragmatic Hodgkin's disease: experience of a rare clinical presentation at St Bartholomew's Hospital.
Hematological oncology 1984;2(4):349-57.
1984: Steven H Swerdlow; J A Habeshaw; A Z Rohatiner; T Andrew Lister; A G Stansfeld
Caribbean T-cell lymphoma/leukemia.
Cancer 1984;54(4):687-96.
1984: M S Dorreen; J A Habeshaw; A G Stansfeld; P F Wrigley; T Andrew Lister
Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.
British journal of cancer 1984;49(4):465-76.
1983: T Andrew Lister; M S Dorreen; M Faux; A E Jones; P F Wrigley
The treatment of stage IIIA Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(12):745-9.
1983: T Andrew Lister; Ama Z S Rohatiner; M L Slevin; H S Dhaliwal; R Bell; G Henry; H Thomas; John A Amess
Short-term therapy for acute myelogenous leukaemia in younger patients.
Haematology and blood transfusion 1983;28():30-5.
1982: J H Waxman; Y A Terry; P F Wrigley; J S Malpas; L H Rees; G M Besser; T Andrew Lister
Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy.
British medical journal (Clinical research ed.) 1982;285(6355):1612-3.
1982: R Bell; Ama Z S Rohatiner; M L Slevin; J M Ford; H S Dhaliwal; G Henry; B G Birkhead; John A Amess; J S Malpas; T Andrew Lister
Short-term treatment for acute myelogenous leukaemia.
British medical journal (Clinical research ed.) 1982;284(6324):1221-4.
1982: M S Dorreen; J A Habeshaw; P F Wrigley; T Andrew Lister
Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.
British journal of cancer 1982;45(4):491-9.
1980: T Andrew Lister; J M Whitehouse; R T Oliver; R Bell; S A Johnson; P F Wrigley; J M Ford; M H Cullen; W Gregory; A M Paxton; J S Malpas
Chemotherapy and immunotherapy for acute myelogenous leukemia.
Cancer 1980;46(10):2142-8.